Myeloid Irs2 deficiency results in enhanced FoxO1 activity in macrophages, which impairs IL-4–induced M2 macrophage activation and predisposes to developing dietary obesity and hyperinsulinemia in mice (56). The gene discussed is FOXO1; the disease is hyperinsulinism.